Troy Edward Wilson - 14 Jul 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, attorney-in-fact for Troy E. Wilson
Issuer symbol
KURA
Transactions as of
14 Jul 2022
Net transactions value
$0
Form type
4
Filing time
21 Feb 2023, 16:04:41 UTC
Previous filing
21 Jun 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Other $0 -468,297 -29% $0.000000 1,151,720 14 Jul 2022 by Red Fish Blue Fish Revocable Trust F1
transaction KURA Common Stock Other $0 -17,708 -1.5% $0.000000 1,134,012 19 Aug 2022 by Red Fish Blue Fish Revocable Trust F1
transaction KURA Common Stock Other $0 -41,318 -3.6% $0.000000 1,092,694 19 Aug 2022 by Red Fish Blue Fish Revocable Trust F2
transaction KURA Common Stock Other $0 +41,318 $0.000000 41,318 19 Aug 2022 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -1,084,300 -99% $0.000000 8,394 06 Oct 2022 by Red Fish Blue Fish Revocable Trust F2
transaction KURA Common Stock Other $0 +1,084,300 +2624% $0.000000 1,125,618 06 Oct 2022 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -11,985 -28% $0.000000 30,525 19 Aug 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +560,000 $0.000000 560,000 16 Feb 2023 Common Stock 560,000 $11.99 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person.
F2 This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person.
F3 Includes 1,109 shares acquired on November 17, 2021 and 1,450 shares acquired on May 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
F4 This option vests in 48 equal monthly installments commencing on the grant date.